Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Cancer
- Disease
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 283199
The Parties have been collaborating in the development of a certain antiestrogen compound as a Licensed Compound under the terms of the Agreement.
Licensee now desires to assume sole responsibility for the continued development of such antiestrogen compound.
Licensed products means any pharmaceutical products in dosage form which contain one or more Licensed Compounds, including without limitation, Licensed Combinations.
Licensed Compounds means (i) any compounds existing on the effective date of this Agreement which were conceived of as antiestrogen or antiandrogen compounds by or on behalf of Licensee and (ii) any additional novel or existing compounds which are conceived of as compounds in the Field by or on behalf of Licensee while carrying out research in the program as that term is defined.
IPSCIO Record ID: 282876
Acolbifene is the chemical compound known as acolbifene hydrochloride, which has the following chemical structure
[2H-1-Benzopyran-7-ol, 3-( 4-hydroxyphenyl)-4-methyl-2-[ 4-[2-(lpiperidinyl)ethoxy]phenyl]-, hydrochloride, (2S)~]and may be alternatively described as
[ (2S)-3-( 4-Hydroxyphenyl)-4-methyl-2-[ 4-(2-piperidin-1-yl-ethoxy)phenyl]-2Hchromen-7-ol]
Acolbifene belongs to a class of compounds known as selective estrogen receptor modulators, or SERMs. SERMs inhibit the stimulatory effect that the female sex hormone estrogen has on the growth of breast and uterine cancer.
Field means the therapeutic and/or prophylactic use of any Licensed Compound or Licensed Product for the treatment of any disease or condition in humans and/or animals.
IPSCIO Record ID: 291134
The patents include but are not limited to Therapeutic Antiestrogens, Estrogen Nucleus Derivatives, and, Estrogen Sensitive Disease.
IPSCIO Record ID: 282875
Licensed Compounds means (I) any compounds existing on the effective date of this Agreement which were conceived of as antiestrogen or antiandrogen compounds by or on behalf of Licensor; (ii) any additional novel or existing compounds which are conceived of as compounds in the Field by or on behalf of Licensor while carrying out research in the Program as that term is defined in Paragraph (a) of Article 4 of this Agreement during the four (4) year period commencing on the effective date of this Agreement, as such period may be extended; and (iii) any novel or existing compounds which are conceived of as compounds in the Field by or on behalf of Licensee and arising from research using the Type-5 Gene Technology, including, without limitation, through use of the Type-5 Gene Technology for compound screening, conducted during the Program (as defined above) or during the two year drug discovery and development period, including as it may be extended. The parties acknowledge and agree that for purposes of determining Net Sales and Earned Royalties Licensed Compounds shall also include compounds discovered by or on behalf of Licensee and arising from research using the Type-5 Gene Technology.
Type-5 Gene Technology means the enzyme known as 17ß-HSD-5. DNA expressing 17ß-HSD-5 (including, without limitation, the wildtype gene and any mutant genes prepared by or on behalf of Licensor), plasmids or other vectors comprising such DNA, transformed or transfected cell lines, assays or screening methods for identifying and/or evaluating the efficacy of compounds which are inhibitors of 17 ß -HSD-5 and any other materials or methods developed by or on behalf of Licensor for use in such assays or screening methods.
Patent Rights means (I) all pending United States patent applications and issued patents relating to Licensed Compounds, including without limitation, the pending United States patent applications and issued patents, as of the effective date of this Agreement; (ii) all claims of any patent applications or issued patents filed or issued during or after the term of this Agreement to which Licensor have rights covering any compositions for, processes for, or methods of use of any Licensed Compounds in the Field; (iii) all existing or future United States patent applications and issued patents relating to Type-5 Gene Technology or the use of Type-5 Gene Technology to screen for or otherwise identify Licensed Compounds; (iv) all claims of any foreign counterpart patent applications and/or issued patents of (I), (ii) or (iii); (v) any reissues, extensions, substitutions, confirmations, registrations, revalidations, additions, continuations, continuations-in-part, divisions or supplementary protection certificates, of or to any of the foregoing which are hereafter granted in the Territory.
“Licensed Compounds†means antiestrogen or antiandrogen compounds.
It can be used to treat women with breast cancer who have or have not gone through menopause.
Antiandrogens, also known as androgen antagonists or testosterone blockers, are a class of drugs that prevent androgens like testosterone and dihydrotestosterone (DHT) from mediating their biological effects in the body.
Use • Men and boys Prostate cancer; Benign
